Zavicefta

Zavicefta

ceftazidime + avibactam

Manufacturer:

Pfizer
Concise Prescribing Info
Contents
Ceftazidime 2 g, avibactam 0.5 g
Indications/Uses
Adults w/ complicated intra-abdominal infection (cIAI) in combination w/ metronidazole. Complicated UTI, including pyelonephritis (cUTI); hospital-acquired pneumonia (HAP), including ventilator-associated pneumonia (VAP).
Dosage/Direction for Use
IV infusion cIAI Patient ≥18 yr 1 vial every 8 hr over 2 hr for 5-14 days. cUTI, including pyelonephritis 1 vial every 8 hr over 2 hr for 5-10 days. HAP, including VAP 1 vial every 8 hr over 2 hr for 7-14 days. Renal impairment CrCl 50-31 mL/min 1,000 mg/250 mg every 8 hr over 2 hr, 30-16 mL/min 750 mg/187.5 mg every 12 hr over 2 hr, 15-6 mL/min 750 mg/187.5 mg every 24 hr over 2 hr, <6 mL/min 750 mg/187.5 mg every 48 hr over 2 hr.
Contraindications
Hypersensitivity to ceftazidime pentahydrate, avibactam Na, Na carbonate or any cephalosporins. Immediate & severe hypersensitivity (eg, anaphylactic reaction) to any other β-lactams eg, penicillins, monobactams or carbapenems.
Special Precautions
Discontinue use if severe hypersensitivity reactions occur. Hypersensitivity reactions to ceftazidime, other cephalosporins or any other β-lactam agents; history of non-severe hypersensitivity to other β-lactam agents. Discontinue treatment for Clostridium difficile. Overgrowth of non-susceptible organisms (eg, enterococci, fungi) due to prolonged use. Patients on controlled Na diet. Medicinal products known to inhibit peristalsis should not be given. Concurrent use w/ nephrotoxic medicinal products eg, aminoglycosides or potent diuretics (eg, furosemide). May cause +ve direct antiglobulin or Coombs' test; false +ve result w/ copper reduction methods (eg, Benedict's, Fehling's, Clinitest). May affect ability to drive & use machines. Renal impairment. Not to be used during prengnay. Interrupt breast-feeding. Childn <18 yr.
Adverse Reactions
Positive Coombs' direct test. Candidiasis (eg, vulvovaginal & oral candidiasis); eosinophilia, thrombocytosis, thrombocytopenia; headache, dizziness; diarrhoea, abdominal pain, nausea, vomiting; increased of ALT & AST, blood alkaline phosphatase, γ-glutamyltransferase & blood LDH; maculo-papular rash, urticaria, pruritus; infusion site thrombosis & phlebitis, pyrexia.
Drug Interactions
Adversely affected renal function w/ nephrotoxic medicinal products eg, aminoglycosides or potent diuretics (eg, furosemide). Antagonism w/ chloramphenicol. Altered elimination w/ probenecid.
MIMS Class
Cephalosporins
ATC Classification
J01DD - Third-generation cephalosporins ; Used in the systemic treatment of infections.
Presentation/Packing
Form
Zavicefta powd for soln for infusion
Packing/Price
(vial) 20 mL x 10 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in